antibody therapy (BioSavita)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantibody therapy (BioSavita)
Drug Alias Nameantibody therapy (ApoLife)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiosavita
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosavita
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A